Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
429.52
+1.47 (0.34%)
Jul 24, 2026, 3:23 PM EST
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $351.25 billion as of July 27, 2026. Its market cap has increased by 34.44% in one year.
Market Cap
351.25B
Enterprise Value
384.97B
Revenue
77.92B
Ranking
n/a
PE Ratio
23.00
Stock Price
$429.52
ChartMarket Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 351.25B, an increase of 3,910.29%. That is a compound annual growth rate of 11.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 351.25B | 5.95% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 808.75M |
| Veradigm | 560.21M |
| Silence Therapeutics | 520.52M |
| Elite Pharmaceuticals | 417.40M |
| American Oncology Network | 404.79M |
| Glorywin Entertainment Group | 359.76M |
| Northwest Biotherapeutics | 289.81M |
| CytoDyn | 271.88M |